News & Articles

AACC 2018 plenary speaker, Professor James Collins, provides an insight into the future of synthetic biology and CRISPR-based diagnostic tools

Perkin Elmer, Inc. launches new products to advance the management of AAV

Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

Fulfil your continuing professional development (CPD) requirements with help from SelectScience’s new accredited webinars

Recent findings show initial testing for three specific biomarkers may provide superior results over standard screening methods

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23

Experts find that the painkiller blocks a key process linked to tumor formation

Wellcome trust to support rapid response in the DRC

Which new product, instrument or consumable has made the most difference to your clinical lab or point-of-care practice? Nominate now for a chance to win a $500/£400/450€ Amazon voucher

Prostate health index (phi) test to be exhibited at the AUA annual meeting in San Francisco

Healthcare wearables company, Activinsights, commended for enterprise in Britain’s top business accolade

Long-term agreement helps ensure a safe and efficient blood supply in the Netherlands

The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics

SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

Experts discuss the expanding role of mass spectrometry in forensic toxicology and drug monitoring research

Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers

From rhinos to chemical warfare agents, we bring you the latest in forensics and toxicology

A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests